Liquidia (LQDA) Change in Account Payables (2020 - 2026)
Liquidia's (LQDA) quarterly Change in Account Payables came in at $562000.0 in Q1 2026, down 83.56% year-on-year from $3.4 million in Q1 2025, and up 128.62% quarter-over-quarter from -$2.0 million in Q4 2025.
Liquidia (LQDA) Change in Account Payables (2020 - 2026) Analysis & Trends
Liquidia's Change in Account Payables history runs 7 years deep, the most recent figure standing at $562000.0 for Q1 2026.
- On a quarterly basis, Change in Account Payables fell 83.56% year-over-year to $562000.0 in Q1 2026; TTM through Mar 2026 was -$5.4 million, a 200.07% decrease from a year earlier, with the FY2025 full-year figure at -$2.6 million, down 211.29% from the prior year.
- Change in Account Payables grew to $562000.0 in Q1 2026 per LQDA's latest filing, from -$2.0 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $3.4 million in Q1 2025 and bottomed at -$6.0 million in Q3 2025.
- The 5-year median for Change in Account Payables is $303000.0 (2024), against an average of -$2294.1.
- Across the five-year window, Change in Account Payables slumped 1857.95% in 2024 and soared 1028.05% in 2025, its largest moves.
- Year by year, Change in Account Payables stood at $1.0 million in 2022, then tumbled by 158.6% to -$596000.0 in 2023, then surged by 528.19% to $2.6 million in 2024, then tumbled by 176.96% to -$2.0 million in 2025, then jumped by 128.62% to $562000.0 in 2026.
- Per Business Quant, the three latest LQDA Change in Account Payables figures stand at $562000.0 (Q1 2026), -$2.0 million (Q4 2025), and -$6.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 30.60 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 32.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Liquidia | 7.84 Bn | 7.61 Bn | 121.79 Mn | 562,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 562,000.00 |
| Mar 31, 2026 | 562,000.00 |
| Dec 31, 2025 | -1.96 Mn |
| Dec 31, 2025 | -1.96 Mn |
| Sep 30, 2025 | -5.99 Mn |
| Sep 30, 2025 | -5.99 Mn |
| Jun 30, 2025 | 1.95 Mn |
| Jun 30, 2025 | 1.95 Mn |
| Mar 31, 2025 | 3.42 Mn |
| Mar 31, 2025 | 3.42 Mn |
| Dec 31, 2024 | 2.55 Mn |
| Dec 31, 2024 | 2.55 Mn |
| Sep 30, 2024 | -3.45 Mn |
| Sep 30, 2024 | -3.45 Mn |
| Jun 30, 2024 | 2.92 Mn |
| Jun 30, 2024 | 2.92 Mn |
| Mar 31, 2024 | 303,000.00 |
| Mar 31, 2024 | 303,000.00 |
| Dec 31, 2023 | -596,000.00 |
| Dec 31, 2023 | -596,000.00 |